Apimeds US board and CEO ousted; new board approves expansion into Korean cosmetics and photo booth

Apimeds Pharmaceuticals US, Inc.

Majority stockholders removed directors Elona Kogan, Jakap Koo, Carol O’Donnell, Dr. Bennett Weintraub via written consent.
CEO Vin Menon and CFO Erick Frim removed; Youngjik Cho appointed CEO, Junyoung Yu as Secretary.
New board approved non-binding MOUs with Assemble, Hilluck (cosmetics distribution) and LK Ventures (Life4Cuts photo booth platform).
Company delays previously announced 1-for-10 reverse stock split; board will continue to evaluate timing.
MindWave issued unauthorized press release challenging the consent; company intends to vigorously defend validity.

item 5.02item 8.01item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.